These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12184868)

  • 21. Inhaled aerosol dose distribution between proximal bronchi and lung periphery.
    Verbanck S; Biddiscombe MF; Usmani OS
    Eur J Pharm Biopharm; 2020 Jul; 152():18-22. PubMed ID: 32361031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant Driven Post-Deposition Spreading of Aerosols on Complex Aqueous Subphases. 1: High Deposition Flux Representative of Aerosol Delivery to Large Airways.
    Khanal A; Sharma R; Corcoran TE; Garoff S; Przybycien TM; Tilton RD
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):382-93. PubMed ID: 25723759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breathing easier: addressing the challenges of aerosolizing medications to infants and preschoolers.
    Goralski JL; Davis SD
    Respir Med; 2014 Aug; 108(8):1069-74. PubMed ID: 25012949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine.
    Klyashchitsky BA; Owen AJ
    J Drug Target; 1999; 7(2):79-99. PubMed ID: 10617295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerosolized Medications for Gene and Peptide Therapy.
    Laube BL
    Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
    Wang YB; Watts AB; Peters JI; Williams RO
    Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abstracts from The Aerosol Society Drug Delivery to the Lungs XVII. November 30-December 1, 2006. Edinburgh, Scotland.
    J Aerosol Med; 2007; 20(3):365-92. PubMed ID: 17894544
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug delivery devices: issues in drug development.
    Byron PR
    Proc Am Thorac Soc; 2004; 1(4):321-8. PubMed ID: 16113453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosolized drug delivery: fractional deposition of inhaled particles.
    Bennett WD
    J Aerosol Med; 1991; 4(3):223-7. PubMed ID: 10147680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An approach to deposition and clearance measurements in human airways.
    Scheuch G; Stahlhofen W; Heyder J
    J Aerosol Med; 1996; 9(1):35-41. PubMed ID: 10160207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted drug-aerosol delivery in the human respiratory system.
    Kleinstreuer C; Zhang Z; Donohue JF
    Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosol delivery through an artificial airway.
    MacIntyre NR
    Respir Care; 2002 Nov; 47(11):1279-88; discussion 1285-9. PubMed ID: 12425743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment methods of inhaled aerosols: technical aspects and applications.
    Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.
    Moller W; Saba GK; Haussinger K; Becker S; Keller M; Schuschnig U
    Rhinology; 2011 Aug; 49(3):286-91. PubMed ID: 21858257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic aerosol targeting of nanoparticles to cancer: nanomagnetosols.
    Rudolph C; Gleich B; Flemmer AW
    Methods Mol Biol; 2010; 624():267-80. PubMed ID: 20217602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfluorocarbon compound aerosols for delivery to the lung as potential 19F magnetic resonance reporters of regional pulmonary pO2.
    Thomas SR; Gradon L; Pratsinis SE; Pratt RG; Fotou GP; McGoron AJ; Podgorski AL; Millard RW
    Invest Radiol; 1997 Jan; 32(1):29-38. PubMed ID: 9007645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosol drug delivery: developments in device design and clinical use.
    Dolovich MB; Dhand R
    Lancet; 2011 Mar; 377(9770):1032-45. PubMed ID: 21036392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol gene therapy.
    Gautam A; Waldrep JC; Densmore CL
    Mol Biotechnol; 2003 Jan; 23(1):51-60. PubMed ID: 12611269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.